作为治疗癌症的治疗工具的Orai1 Ca2+通道调节器:新兴证据!
Olivier Mignen1, Jean-Pierre Vannier2, Pascale Schneider2
1LBAI, UMR1227, Univ Brest, Inserm, Brest, France.
Biochemical pharmacology
|December 1, 2023
概括
通过向入路,Orai1通道调节器显示出对癌症治疗的希望. 这些调节器为各种癌症提供潜在的治疗益处,影响细胞增殖和转移.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蛋白对于进入不可激发细胞至关重要,调节储存运行进入 (SOCE) 和储存独立的进入 (SICE) 途径.
- 这些信号通路的失调与瘤细胞增多,迁移,转移和血管生成有关.
- 关键的Orai蛋白Orai1被认为是各种疾病的重要治疗点.
研究的目的:
- 审查Orai1通道调节器作为潜在治疗药物的重要性.
- 突出Orai1调节器在癌症治疗中的治疗价值.
- 讨论Orai1在癌症进展中的作用及其作为药物点的潜力.
主要方法:
- 对Orai1功能,信号传递和治疗应用研究的文献综述.
- 对临床前和临床环境中的Orai1抑制剂和调节剂现有数据的分析.
- 综合了有关Orai1对癌症特征影响的信息.
主要成果:
- 在治疗牛皮和胰腺炎等疾病的试验中,已经研究了Orai1通道抑制剂.
- 新出现的证据表明,Orai1通道调节器可能具有抗癌性质.
- 向Orai1提供了一个潜在的策略来抑制瘤生长和转移.
结论:
- Orai1通道调节器代表了一类有前途的治疗工具.
- 调节Orai1通道对于开发新型癌症疗法具有重大潜力.
- 对Orai1调节器的进一步研究可能会导致对各种癌症的有效治疗.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Non-gated Ion Channels
6.8K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


